Immucell (ICCC) Other Accumulated Expenses (2023 - 2026)

Immucell (ICCC) has reported Other Accumulated Expenses for 4 consecutive years, with $30832.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Other Accumulated Expenses fell 79.14% year-over-year to $30832.0; the trailing twelve-month figure through Jun 2026 stood at $30832.0 (down 79.14% YoY), and the FY2025 full-year result was $22226.0, down 90.52% from the prior year.
• Other Accumulated Expenses rose to $30832.0 in Q2 2026 per ICCC's latest filing, from $22226.0 in the prior quarter.
• Across five years, Other Accumulated Expenses topped out at $376112.0 in Q3 2024 and bottomed at $22226.0 in Q4 2025.
• Historically, Other Accumulated Expenses has averaged $175079.6 across 4 years, with a median of $170272.0 in 2023.
• The sharpest annual moves came in 2024 and 2025: Other Accumulated Expenses increased 21.68% in 2024, then sank 90.52% in 2025.
• Over 4 years, Other Accumulated Expenses stood at $192754.0 in 2023, then climbed by 21.68% to $234552.0 in 2024, then tumbled by 90.52% to $22226.0 in 2025, then surged by 38.72% to $30832.0 in 2026.
• According to Business Quant data, Other Accumulated Expenses over the past three periods registered $30832.0, $22226.0, and $264832.0 for Q2 2026, Q4 2025, and Q3 2025 respectively.